A new report published by Fact.MR estimates the global recombinant protein market to witness expansion at a moderate CAGR during the forecast period 2017 to 2022. Revenues from the global recombinant protein market will reach nearly US$ 460 Mn by 2022-end.
The recombinant protein market involves production of therapeutic proteins and drugs using recombinant DNA technology and cell culture. Recombinant proteins find wide applications in biopharmaceuticals development for treating conditions such as diabetes, cancer, arthritis and cardiovascular diseases. They serve as alternatives to proteins isolated from animal tissues in drug formulation. The recombinant protein technology helps in mass production of consistent and safe human proteins of ... Read more
